Quarterly Result3 Sept 2026, 12:39 pm
Caplin Point FY26 Revenue ₹2,187 Cr, Profit ₹650 Cr
AI Summary
Caplin Point Laboratories Ltd announced its Annual Report for FY26, highlighting robust financial performance. Revenue grew 12.89% to ₹2,187 Crores, with net profit surging 20.08% to ₹650 Crores. The company emphasized a decade-long pattern of profit compounding at approximately 27% without debt funding. Key developments include Caplin Steriles USA achieving profitability in its first year, backward integration, and expansion plans in Mexico and Guatemala. Free cash reserves stand at ₹1,471 Crores, showing 21X growth over the decade. The 35th Annual General Meeting is scheduled for September 25, 2026.
Key Highlights
- FY26 revenue reached ₹2,187 Cr, a 12.89% year-on-year increase.
- Net profit for FY26 was ₹650 Cr, up 20.08% year-on-year.
- Profit has compounded at ~27% annually over the last decade.
- Free cash reserves grew 21X to ₹1,471 Cr over the past decade.
- Expansion in Mexico and Guatemala planned without leverage.
Price Impact
More from CAPLIPOINT